Alexander B Benson1, Gregory L Austin2, Mary Berg3, Kim K McFann4, Sila Thomas5, Gina Ramirez5, Hugo Rosen2, Christopher C Silliman5, Marc Moss6. 1. Division of Pulmonary Sciences and Critical Care, University of Colorado Denver, Anschutz Medical Campus Research 2, Box C272, 9th floor, 12770 East 19th Ave., Aurora, CO, 80045, USA. Alexander.benson@ucdenver.edu. 2. Division of Gastroenterology and Hepatology, University of Colorado Denver, Aurora, CO, 80045, USA. 3. Department of Pathology, University of Colorado Denver, Aurora, CO, 80045, USA. 4. School of Public Health, University of Colorado Denver, Aurora, CO, 80045, USA. 5. Bonfils Blood Center, Denver, CO, USA. 6. Division of Pulmonary Sciences and Critical Care, University of Colorado Denver, Anschutz Medical Campus Research 2, Box C272, 9th floor, 12770 East 19th Ave., Aurora, CO, 80045, USA.
Abstract
PURPOSE: Transfusion of blood components is common in patients admitted to the intensive care unit (ICU) for gastrointestinal (GI) bleeding, yet the incidence and risk factors for development of transfusion-related acute lung injury (TRALI) in these patients are unknown. METHODS: Patients admitted to a medical ICU for GI bleeding (n = 225) were analyzed for patient- and transfusion-specific risk factors for development of TRALI. RESULTS: In transfused patients (n = 150), the incidence of TRALI was 15% [95% confidence interval (CI), 10-21%] and accounted for 76% (22/29) of all acute lung injury (ALI) cases. Transfused patients with end-stage liver disease (ESLD) (n = 72) developed TRALI more frequently than those without ESLD (29% versus 1%, p < 0.01). Fresh frozen plasma (FFP) was temporally associated with TRALI in 86% of cases. Transfusion-specific risk factors for development of TRALI included number of transfused units of FFP and nonleukoreduced red blood cells. Patient-specific risk factors included Model for End-Stage Liver Disease (MELD) score, admission serum albumin level, and presence of ALI risk factors. CONCLUSIONS: TRALI is common in critically ill ESLD patients with gastrointestinal bleeding. Nonleukoreduced red blood cells and FFP are significant transfusion-specific risk factors and their use should be re-evaluated in bleeding patients with ESLD.
PURPOSE: Transfusion of blood components is common in patients admitted to the intensive care unit (ICU) for gastrointestinal (GI) bleeding, yet the incidence and risk factors for development of transfusion-related acute lung injury (TRALI) in these patients are unknown. METHODS: Patients admitted to a medical ICU for GI bleeding (n = 225) were analyzed for patient- and transfusion-specific risk factors for development of TRALI. RESULTS: In transfused patients (n = 150), the incidence of TRALI was 15% [95% confidence interval (CI), 10-21%] and accounted for 76% (22/29) of all acute lung injury (ALI) cases. Transfused patients with end-stage liver disease (ESLD) (n = 72) developed TRALI more frequently than those without ESLD (29% versus 1%, p < 0.01). Fresh frozen plasma (FFP) was temporally associated with TRALI in 86% of cases. Transfusion-specific risk factors for development of TRALI included number of transfused units of FFP and nonleukoreduced red blood cells. Patient-specific risk factors included Model for End-Stage Liver Disease (MELD) score, admission serum albumin level, and presence of ALI risk factors. CONCLUSIONS: TRALI is common in critically ill ESLD patients with gastrointestinal bleeding. Nonleukoreduced red blood cells and FFP are significant transfusion-specific risk factors and their use should be re-evaluated in bleeding patients with ESLD.
Authors: Michelle Ng Gong; B Taylor Thompson; Paige Williams; Lucille Pothier; Paul D Boyce; David C Christiani Journal: Crit Care Med Date: 2005-06 Impact factor: 7.598
Authors: Jean Louis Vincent; Jean-François Baron; Konrad Reinhart; Luciano Gattinoni; Lambert Thijs; Andrew Webb; Andreas Meier-Hellmann; Guy Nollet; Daliana Peres-Bota Journal: JAMA Date: 2002-09-25 Impact factor: 56.272
Authors: Ognjen Gajic; Rimki Rana; Jose L Mendez; Otis B Rickman; James F Lymp; Rolf D Hubmayr; S Breanndan Moore Journal: Transfusion Date: 2004-10 Impact factor: 3.157
Authors: Darius Sorbi; Christopher J Gostout; David Peura; David Johnson; Frank Lanza; P Gregory Foutch; Cathy D Schleck; Alan R Zinsmeister Journal: Am J Gastroenterol Date: 2003-11 Impact factor: 10.864
Authors: Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro Journal: Crit Care Med Date: 2004-01 Impact factor: 7.598
Authors: Ognjen Gajic; Rimki Rana; Jeffrey L Winters; Murat Yilmaz; Jose L Mendez; Otis B Rickman; Megan M O'Byrne; Laura K Evenson; Michael Malinchoc; Steven R DeGoey; Bekele Afessa; Rolf D Hubmayr; S Breanndan Moore Journal: Am J Respir Crit Care Med Date: 2007-07-12 Impact factor: 21.405
Authors: Onuma Chaiwat; John D Lang; Monica S Vavilala; Jin Wang; Ellen J MacKenzie; Gregory J Jurkovich; Frederick P Rivara Journal: Anesthesiology Date: 2009-02 Impact factor: 7.892
Authors: Alexander B Benson; James R Burton; Gregory L Austin; Scott W Biggins; Michael A Zimmerman; Igal Kam; Susan Mandell; Christopher C Silliman; Hugo Rosen; Marc Moss Journal: Liver Transpl Date: 2011-02 Impact factor: 5.799
Authors: Lisa K Vande Vusse; Ellen Caldwell; Edward Tran; Laurie Hogl; Steven Dinwiddie; José A López; Ronald V Maier; Timothy R Watkins Journal: Ann Am Thorac Soc Date: 2015-09
Authors: Junghyun Kim; Trang T T Nguyen; Yue Li; Chen-Ou Zhang; Boyoung Cha; Yunbo Ke; Michael A Mazzeffi; Kenichi A Tanaka; Anna A Birukova; Konstantin G Birukov Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-01-08 Impact factor: 5.464